Updates: Retina
ASGCT 2025: Transforming Gene and Cell Therapy
A central theme of the meeting was the expansion of the gene and cell therapy toolbox. Researchers and clinicians are moving beyond traditional modalities by adopting new technologies and…
Read update
ARVO 2025: Complexity, Confidence, and the Case for In Vitro
Fresh from ARVO 2025, it’s clear that ophthalmic research is entering a new chapter—one defined by increased model sophistication, deeper mechanistic insight, and a growing appetite for translational relevance….
Read update
Announcement: New scientific publication in collaboration with the University of Newcastle
Newcells Biotech, in collaboration with Newcastle University, is proud to announce a new scientific publication showcasing cutting-edge research into Stargardt disease. In this study patient-derived retinal…
Read update
Transforming Drug Development with 3D Retina Models
Newcells Biotech Limited, a team of internationally recognised experts in the building and application of complex models of human tissues for drug discovery, was awarded £1m to deliver their…
Read update
Newcells Biotech strengthens executive and US team with key appointments
Dr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor New US commercial appointments also announced…
Read update
ARVO Highlights
About the conference: ARVO The ARVO conference took place in the New Orleans Ernest N. Morial Convention Center. With over 10 000 attendees, the venue was absolutely huge. If you…
Read update
